Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Yangyihua Zhou
Institution:
Academy of Military Medical Sciences
Observed institutions:
Central South University,
Hunan Normal University,
Henan University,
Academy of Military Medical Sciences,
Chinese PLA General Hospital,
First Affiliated Hospital of Henan University,
Xiangya Hospital Central South University,
Dali University
show all 8
ORCID:
0000-0002-9247-7281
Observed ORCID:
0000-0002-9247-7281
OpenAlex ID:
A5025109976
The application of Interleukin-2 family cytokines in tumor immunotherapy research
2023
·
Yangyihua Zhou
, Guiqi Quan
, et al.
·
Frontiers in Immunology
·
50
PDF
PD-1/LAG-3 bispecific antibody potentiates T cell activation and increases antitumor efficacy
2022
·
Ning Shi
, Yangyihua Zhou
, et al.
·
Frontiers in Immunology
·
43
A high-affinity CEA-targeted nanobody for 68Ga PET imaging and 177Lu-based radioisotope therapy: preclinical and first-in-human evaluation
2025
·
Liang Zhang
, Ming Zhou
, et al.
·
Journal of Nanobiotechnology
·
22
PDF
Broad‐Spectrum Engineered Multivalent Nanobodies Against SARS‐CoV‐1/2
2024
·
Zhihong Wang
, Zhuangzhuang Shi
, et al.
·
Advanced Science
·
13
Novel Quaternary Ammonium Salt‐Linked STING Agonist Antibody‐Drug Conjugate: Synergistic Activation of Tumor Immunity with Mitigated Off‐Target Toxicity
2025
·
Yu Long
, Borui Tang
, et al.
·
Advanced Science
·
11
PDF
Structure-guided affinity maturation of a novel human antibody targeting the SARS-CoV-2 nucleocapsid protein
2022
·
Zhihong Wang
, Naijing Hu
, et al.
·
Scientific Reports
·
11
PDF
Anti-Claudin18.2-IL-21 fusion protein bifunctional molecule has more powerful anti-tumor effect and better safety
2022
·
Yangyihua Zhou
, Guiqi Quan
, et al.
·
International Immunopharmacology
·
10
Detection of TNF-α using the established ab-MPs-CLIA
2024
·
Liang Zhang
, Pinnan Zhao
, et al.
·
Talanta
·
9
Screening and Identification of a Novel Anti–Siglec-15 Human Antibody 3F1 and Relevant Antitumor Activity
2022
·
Jiaguo Wu
, Jingyi Peng
, et al.
·
Molecular Pharmacology
·
9
PDF
Development and Characterization of 4A7: A High-Affinity Monoclonal Antibody Targeting Claudin18.2
2025
·
Yahui Wu
, Juan Tian
, et al.
·
ImmunoTargets and Therapy
·
6
Comparative evaluation of bispecific antibody formats targeting PD-1 and LAG-3 for dual checkpoint blockade in cancer immunotherapy
2025
·
Jie Wang
, Ning Shi
, et al.
·
Biomedicine & Pharmacotherapy
·
4
Reshaping antivenom therapy: A triple-synergy strategy featuring broadly neutralizing antibodies and a small-molecule PLA2 inhibitor
2025
·
Yangyihua Zhou
, Ning Shi
, et al.
·
Acta Pharmaceutica Sinica B
·
4
Clostridium perfringens alpha toxin drives pathological NETosis via immature neutrophil mobilization and functional reprogramming
2025
·
Pinnan Zhao
, Zongcheng Li
, et al.
·
Acta Pharmaceutica Sinica B
·
3
Physics-Informed Artificial Intelligence Design of Picomolar Nanobodies Enables Deep Tumor Penetration and High-Contrast Imaging
2026
·
Ning Shi
, Caiping Ren
, et al.
·
Research
·
2
Beyond the magic bullet: Programming delivery systems to overcome the antibody specificity paradox
2026
·
Yaowei Ma
, Yangyihua Zhou
, et al.
·
Journal of Controlled Release
·
1
Fc₉₅, a next-generation Fc variant, achieves exceptional ADCC potency by linking affinity enhancement to intrinsic afucosylation
2026
·
longlong Luo
, Yangyihua Zhou
, et al.
·
Research Square
PDF
Show more works
View as search
Works count:
16
Citation count:
198
H-index:
9
I10-index:
7
Year
Topic
Type